Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
TOT BIOPHARM International Co. Ltd. ( (HK:1875) ) has issued an announcement.
BioDlink International Company Limited, a Hong Kong-based company, announced significant changes in its leadership structure. Mr. Fu, Shan has been re-designated from a non-executive director to an executive director, continuing his role as chairperson of the Board and various committees. This change positions Mr. Fu to lead and oversee the management and development of the company, potentially impacting its strategic direction and stakeholder relations.
The most recent analyst rating on (HK:1875) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on TOT BIOPHARM International Co. Ltd. stock, see the HK:1875 Stock Forecast page.
More about TOT BIOPHARM International Co. Ltd.
Average Trading Volume: 411,897
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.66B
Find detailed analytics on 1875 stock on TipRanks’ Stock Analysis page.